Building Robust Transcriptomes with Master Splicing Factors by Sharp, Phillip A. & Jangi, Mohini Rohit
BUILDING ROBUST TRANSCRIPTOMES WITH MASTER 
SPLICING FACTORS
Mohini Jangi1 and Phillip A. Sharp1,2
1David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 
Cambridge MA 02139
2Department of Biology, Massachusetts Institute of Technology, Cambridge MA 02139
Abstract
Coherent splicing networks arise from many discrete splicing decisions regulated in unison. Here, 
we examine the properties of robust, context-specific splicing networks. We propose that a subset 
of key splicing regulators, or “master splicing factors,” respond to environmental cues to establish 
and maintain tissue transcriptomes during development.
Design principles of robust splicing networks
The epigenetic landscape of differentiation defined by Conrad Waddington nearly 60 years 
ago proposed that homeostatic mechanisms maintained multiple irreversible cell states, 
providing an early suggestion that both stability and plasticity were critical components of 
biological networks (Waddington, 1957). While ensuing efforts focused on understanding 
the role of transcriptional programs in homeostasis or differentiation, the importance of the 
post-transcriptional contribution to these processes is now reaching the forefront. Several 
recent lines of evidence suggest that splicing networks are composed of highly 
interconnected events, conferring stability to the system while simultaneously maintaining 
responsiveness to external stimuli. This is the definition of a “robust” network (Kitano, 
2004). Along with transcriptional and other post-transcriptional effects, splicing contributes 
a layer of regulation integral to the establishment of tissue transcriptomes.
While nearly all mammalian genes undergo alternative splicing (AS) in some context (Wang 
et al., 2008), only a minority of splicing events are conserved across evolution; nevertheless, 
this population has provided critical insights into the role of AS in gene networks (Barbosa-
Morais et al., 2012; Merkin et al., 2012). Most conserved splicing events tend to maintain 
reading frame and encode alternative protein variants (Barbosa-Morais et al., 2012; Merkin 
et al., 2012). However, a substantial fraction of conserved splicing events introduce 
premature termination codons (PTC) and lead to downregulation of the transcript through 
the process of nonsense-mediated mRNA decay (NMD) (Baek and Green, 2005). Recent 
estimates from gene expression profiling suggest that in fact, as many as 10–30% of 
mammalian genes may be regulated by alternative splicing-coupled NMD (AS-NMD) in 
particular contexts (Lewis et al., 2003; Mendell et al., 2004; Weischenfeldt et al., 2012). The 
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coordination of AS-NMD with alternative protein isoform production generates regulatory 
motifs in splicing networks. Understanding the behavior of these individual network motifs 
within the context of larger networks reveals insights into how splicing regulation impacts 
cell fate decisions.
Negative autoregulation maintains homeostasis
When compared to a simply regulated expression system (in which one gene product drives 
expression of another), a negatively autoregulated system (in which a gene product feeds 
back on its own production) is characterized by faster response times and reduced cell-to-
cell variability in the concentration of a gene product. This consequently results in a single 
steady state of the gene product that is buffered against variations in transcriptional output or 
protein stability (Alon, 2007; Becskei and Serrano, 2000; Nevozhay et al., 2009; Rosenfeld 
et al., 2002). In Waddington’s metaphoric terms, this buffering contributes to the 
“canalization” that contains a cell within the steep valleys of the epigenetic landscape 
(Waddington, 1957). It is now understood that many RNA binding proteins (RBPs) undergo 
negative autoregulation through AS-NMD (Figure 1A). A key observation leading to this 
discovery was that AS-NMD events tend to be enriched in genes encoding splicing factors 
and are often ultraconserved, meaning they fall within regions of particularly high 
evolutionary conservation (Lareau et al., 2007; Ni et al., 2007; Wollerton et al., 2004). These 
studies specifically focused on AS-NMD regulation of SR proteins, a family of serine-
arginine-rich RBPs with various roles in RNA processing and required for splicing (Long 
and Caceres, 2009), and hnRNP proteins, a diverse group of RBPs thought to function most 
commonly as splicing repressors (Martinez-Contreras et al., 2007). These proteins were 
shown to be able to bind their own transcripts, cause splicing of the NMD variant, and 
downregulate protein levels to maintain homeostatic protein expression (Lareau et al., 2007; 
Ni et al., 2007; Saltzman et al., 2008). Beyond AS-NMD regulation of SR and hnRNP 
proteins, negative autoregulation of RBPs can also occur via the production of nonfunctional 
or dominant negative protein isoforms (Damianov and Black, 2010). Additionally, proteins 
with enzymatic activity that lack the ability to bind RNA directly can nevertheless exert 
autoregulatory feedback by enzymatically modifying RBPs. One example of this type of 
feedback loop is the SR protein kinase Clk1, whose pre-mRNA undergoes increased 
productive splicing in response to small-molecule inhibition of its own kinase activity 
(Ninomiya et al., 2011).
Positive feedback generates bistability
In contrast to negative feedback, positive autoregulation is characterized by slower response 
times and increased noise in protein expression (Maeda and Sano, 2006). Biologically, the 
effect of positive feedback is to convert a graded input, such as a growth factor signal, into a 
binary output, such as proliferation vs. differentiation (Becskei et al., 2001). This is known 
as ultrasensitivity. If positive feedback is strong, it can produce two distinct steady states, or 
bistability, with stochastic fluctuations in gene expression driving the switch from one 
steady state to another (Alon, 2007; Blake et al., 2003). Unlike negative feedback, which 
generally returns a system to its original state after a perturbation, positive feedback can 
induce memory of a transient signal by reinforcing a new cell state even after the initiating 
signal has disappeared (Alon, 2007).
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Splicing factors do not usually positively regulate the productive splicing of their own pre-
mRNA. However, interaction between two different splicing factors can generate positive 
feedback and bistability. Double-negative feedback loops, in which two factors repress one 
another, can also generate two steady states, each with only one of the two factors expressed 
(Alon, 2007). As negative autoregulation of RBPs occurs so frequently, double-negative 
feedback is likely to be a common motif in splicing regulatory networks (Figure 1B). RBPs 
can also feature in positive feedback loops alongside transcription factors, for example 
during the regulation of developmental decisions (Figure 1B). A recent study investigated 
the role of positive feedback between OCT4, SRSF2, and the methyl-CpG-binding protein 
MBD2 in determining the switch between pluripotency and differentiation of embryonic 
stem cells (ESCs). Here, the ESC master transcription factor OCT4 drives expression of the 
splicing factor SRSF2, which generates an isoform of MBD2 that promotes OCT4 
expression. If SRSF2 expression is sufficiently decreased, however, MBD2 is spliced to 
produce an isoform that represses expression of core ESC transcription factors. This 
composite positive feedback loop therefore maintains pluripotency in the first instance and 
helps drive differentiation in the second, based on the dosage of the components within the 
network (Lu et al., 2014). Similarly, the neuronal splicing regulator nSR100 participates in a 
positive feedback loop with REST, a transcriptional repressor of neurogenesis. In the 
presence of nSR100, REST is spliced to produce an isoform with greatly diminished 
repressive activity. As nSR100 is itself repressed by REST, a differentiated cell state 
characterized by high nSR100 activity and low REST activity is reinforced through positive 
feedback (Raj et al., 2011).
Crossregulation tunes steady states
The steady state expression level of a gene undergoing negative autoregulation tends toward 
the value of its repression threshold, which is the concentration of the gene product needed 
to repress its production by 50% (Alon, 2006). We might consequently predict that splicing 
factors that are negatively autoregulated would maintain similar steady state expression 
levels across tissues, regardless of transcriptional activity. Conversely, RBP expression 
patterns do indeed show cell type-specificity (de la Grange et al., 2010; Grosso et al., 2008), 
implying that additional post-transcriptional regulatory inputs must influence steady state. 
On an evolutionary timescale, the repression threshold and consequently the steady state 
level can be altered by mutation, for example by strengthening or weakening the binding site 
of a transcription factor at its own promoter. Tissue-to-tissue variation, however, cannot be 
explained by mutation. Moreover, as AS-NMD events within RBPs tend to be deeply 
conserved (Lareau et al., 2007; Ni et al., 2007), variations in RBP gene expression among 
species are unlikely to have arisen from differences in the strength of RBP binding to its 
transcript. Instead, extensive crossregulation between RBPs may be one mechanism that 
alters steady state RBP expression across cell types and across species. For example, 
splicing of an autoregulated poison cassette within one RBP can be competitively inhibited 
by the binding of a second RBP. This raises the effective concentration of the first RBP 
necessary for autoregulation and results in its increased steady state expression in the 
presence of the second RBP. Negative autoregulation thus likely cooperates with cross-
regulation to ensure robust and tunable RBP expression patterns.
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Data from a number of recent studies support the model that crossregulation of RBP 
negative feedback modulates splicing networks while maintaining their stability. We 
recently identified thousands of in vivo Rbfox2 binding sites and hundreds of Rbfox2-
regulated splicing events across the mouse ESC transcriptome using iCLIP and RNAseq. 
From these parallel approaches, we identified a large class of Rbfox2-regulated splicing 
events that are rendered silent by NMD. A significant fraction of these NMD splicing events 
fell in the previously-described category of conserved autoregulatory splicing events within 
RBPs (Lareau et al., 2007; Ni et al., 2007). Cross-regulation of this autoregulatory splicing 
by Rbfox2 set the efficacy of autoregulation, and thus the steady-state expression of the gene 
(Figure 2A). This suggested that Rbfox2 tunes the autoregulation and gene expression of a 
network of RBPs, and that changes in Rbfox2 expression activate direct Rbfox2-dependent 
splicing changes as well as a cascade of secondary splicing changes (Jangi et al., 2014). 
These events, together, define the complete Rbfox2 splicing regulatory network.
Crossregulation of autoregulatory splicing has emerged as a common motif in several other 
splicing networks. Two members of the hnRNP family of splicing regulators, hnRNP L and 
hnRNP L-like, have been shown to bind their own and each other’s transcripts to regulate 
gene expression through AS-NMD (Rossbach et al., 2009). A genome-wide analysis of 
hnRNP binding and activity in human 293T cells revealed a high frequency of 
crossregulation between many hnRNP family members, including the regulation of several 
events previously shown to be associated with NMD (Huelga et al., 2012). More generally, 
hnRNP-bound transcripts were significantly enriched for RNA processing genes; 70% of all 
RBP transcripts were bound by at least one hnRNP, with greater than 25% of these showing 
evidence of gene expression or splicing regulation (Huelga et al., 2012). Similarly, the core 
spliceosomal protein SmB/B’ autoregulates its expression through AS-NMD (Saltzman et 
al., 2008). Depletion of SmB/B’ in human tissue culture cells led to widespread changes in 
splicing and expression of RBPs in a manner attributable to AS-NMD (Saltzman et al., 
2011). CLIP signal enrichments of the RBP FUS and the SR protein Srsf3 in highly-
conserved introns of other RBPs suggest that this is a general feature of splicing networks 
(Anko et al., 2012; Nakaya et al., 2013). Such interconnected networks may serve to 
stabilize splicing patterns within a particular cellular condition.
Signal amplification in splicing cascades
Crossregulated splicing events, like transcription factors and signaling components, can be 
integrated into cascades to achieve multiple responses to different inputs. CLIP and 
transcriptome analysis following changes in RBP activity that identified directly-bound 
splicing targets also identified many secondary or indirect targets that likely arise from 
changes in expression of the primary RBP targets (Huelga et al., 2012; Jangi et al., 2014; 
Saltzman et al., 2011). One biological function of this effect is to amplify the original signal, 
in this case the change in expression or activity of the RBP at the top of the cascade, while 
maintaining robustness against stochastic fluctuations in gene expression. Such a mechanism 
may determine splicing changes during the establishment of neuronal precursors in the 
developing brain. Here, the increase in Rbfox2 expression likely contributes to the increased 
expression of Ptbp2 through suppression of its autoregulatory AS-NMD. Several direct 
targets of Ptbp2 in mouse neocortex are also indirect targets of Rbfox2 in embryonic stem 
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cells (Jangi et al., 2014; Licatalosi et al., 2012). This suggests that Rbfox2-dependent 
upregulation of Ptbp2 expands and reinforces the Rbfox2 splicing network that plays an 
integral role in the specification of neuronal lineages (Gehman et al., 2012; Jangi et al., 
2014; Licatalosi et al., 2012) (Figure 2B). In this manner, a “master splicing regulator” – 
positioned at the top of a splicing cascade – could play a critical role in the determination of 
cell fate.
Master splicing regulators and cell identity
Studies in the definition of cell identity have revealed that the expression of a relatively 
small number of transcription factors, termed master transcription factors, can initiate 
commitment along a diverse array of developmental lineages (Young, 2011). 
Characterization of splicing changes across tissues (Merkin et al., 2012) as well as RNA-
protein interaction maps (Witten and Ule, 2011) have raised the intriguing possibility that an 
analogous subset of master splicing regulators exists among splicing factors.
We propose that a putative master splicing regulator plays one or both of two critical roles in 
the implementation of a genetic program. First, the factor may be required for the proper 
differentiation or specification of a cell type. These factors are likely to be expressed in a 
tissue-specific manner. In the absence of the master splicing regulator, differentiation would 
be incomplete due to the misregulation of its splicing network. Conversely, ectopic 
expression of a master splicing regulator in a cell type where it is not normally expressed 
may drive the cell toward the phenotype of a cell in which it is normally expressed. Such 
master splicing regulators involved in lineage specification may generate switch-like 
behavior by directing splicing networks that contain positive feedback loops. Second, once a 
cell is committed to a lineage, a master splicing regulator may be required for maintaining 
homeostasis. This role probably requires secondary splicing regulators acting downstream of 
the master regulator to be negatively autoregulated, thus buffering against variations in the 
cellular environment. While master splicing regulators involved in maintaining cell identity 
may again be lineage-specific, the secondary splicing factors that they regulate, such as SR 
proteins and hnRNPs, may be ubiquitously expressed. Direct and indirect targets of 
homeostatic master splicing factors are likely to be functionally related, allowing for the 
regulation of specific cell functions.
Potential master splicing factors are likely to be highly regulated, such that their splicing 
networks are activated only in the correct settings. In order to perturb a stable splicing 
network sufficiently to transition to a new state, initiating signals would have to arise outside 
of the network itself. These signals are thus likely to be transcriptional, translational, post-
translational, or otherwise splicing-independent. The various modes of splicing factor 
activation may have distinct effects on the kinetics and reversibility of the corresponding 
change in splicing network. Moreover, a master splicing factor may have dynamic 
expression patterns that vary over a range that is not limited by negative feedback. For 
example, transcriptional activation of a master splicing factor gene would steadily increase 
its expression and activity until reaching the threshold of autoregulation, with its splicing 
network maximally activated at this threshold.
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Lineage-specifying splicing cascades
Several examples of RBPs functioning as master regulatory hubs driving broad splicing 
networks during development can be found in the literature. In some of these cases, 
autoregulation, crossregulation, and feedback play critical roles in initiating robust and 
dynamic splicing cascades with distinct outcomes. Although candidate master RBPs 
frequently function downstream of larger transcriptional programs, several of these systems 
also rely on AS regulation of transcription factors. The evidence presented below suggests 
that through this interplay of transcriptional and post-transcriptional effects, the activation of 
key RBPs may be necessary and even sufficient to establish cell identity. Here, we discuss 
instances and properties of splicing networks driven by master splicing regulators in the 
context of differentiation.
Drosophila sex determination
The up- or downregulation of a critical RBP, most likely one that is expressed in a tissue-
restricted manner, could initiate a splicing network and downstream gene expression 
changes that lead to a stable change in cell identity. Perhaps the best understood and most 
remarkable example of a bistable splicing regulatory cascade dependent on autoregulation 
and crossregulation is the Drosophila melanogaster somatic sex determination pathway 
(Figure 3). Here, sex-specific expression of the splicing repressor Sex Lethal (Sxl) specifies 
female development through activation of the RBP Transformer (Tra) and repression of 
Male-Specific Lethal 2 (Msl2) (Schutt and Nothiger, 2000). Sxl, the master splicing 
regulator at the top of the sex-determination pathway, is unproductively spliced in 
developing male flies (Bell et al., 1991). During early embryogenesis, a transcriptional 
signal determined by the ratio of X chromosomes to autosomes (X:A) transiently activates 
an upstream Sxl promoter in female flies. The resulting transcript encodes active Sxl protein 
(Keyes et al., 1992). Active Sxl reinforces productive splicing from the constitutive 
downstream promoter in a positive feedback loop in females, while in males, the lack of 
active Sxl leads to continual production of nonfunctional Sxl. A key target of Sxl is the SR 
protein Tra, which is transcribed in both sexes but is only productively spliced in females in 
an Sxl-dependent manner (Sosnowski et al., 1989). Tra in turn regulates the splicing of two 
transcription factors, Fruitless (Fru) and Doublesex (Dsx), resulting in default male-specific 
isoforms in the absence of Tra and female-specific isoforms in its presence (Hertel et al., 
1996; Lynch and Maniatis, 1996; Tian and Maniatis, 1993). Tra has also been suggested to 
positively feed back on Sxl splicing, further stabilizing the female differentiation program 
(Siera and Cline, 2008). In parallel, Sxl targets the dosage compensation regulator Msl2 to 
cause intron retention and a block in translation in females, while a functional protein is 
produced in males (Bashaw and Baker, 1995; Zhou et al., 1995). The downstream 
transcriptional regulators Msl2, Fru, and Dsx establish much of the sexual dimorphism in 
somatic tissues (Coschigano and Wensink, 1993). Although this Drosophila pathway is not 
conserved among insects, splicing-dependent positive feedback is a recurring theme in 
insect sex determination, suggesting that the use of a splicing cascade confers an 
evolutionary advantage in this bistable system (Salz, 2011).
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MBNL1 and cellular reprogramming
Analogous splicing cascades with such distinct phenotypic consequences have yet to be 
characterized in mammalian systems. Yet several recent reports have demonstrated that 
altering the expression of individual splicing factors can prime cells toward a different cell 
state. Splicing changes occurring during mesodermal differentiation correlate with the 
activity of the MBNL family of splicing regulators (Venables et al., 2013). More causally, in 
human and mouse fibroblasts, knockdown of MBNL1 increases the efficiency of 
reprogramming to iPSCs, while overexpression in human ESCs results in mesodermal 
splicing patterns (Han et al., 2013). The effect on reprogramming has been primarily 
attributed to MBNL1-dependent splicing of the transcription factor FOXP1, of which the 
ES-specific isoform (FOXP1-ES) represses differentiation-specific genes and activates key 
pluripotency genes due to an altered DNA binding domain (Gabut et al., 2011). Importantly, 
the increased reprogramming efficiency caused by MBNL1 knockdown is not phenocopied 
by overexpression of FOXP1-ES, implying that additional targets of MBNL1 are involved in 
this process (Gabut et al., 2011; Han et al., 2013). During cardiomyocyte maturation, 
MBNL1-dependent splicing changes are enriched for spliceosomal genes, and gene 
expression changes across this transition are enriched for components of the splicing 
machinery (Giudice et al., 2014). We can speculate that although a subset of splicing 
changes during these developmental transitions are likely direct targets of MBNL1, many of 
the events attributed to MBNL1 regulation may in fact arise from MBNL1-dependent 
modulations in the expression of other splicing components. These splicing cascades not 
only amplify the signal initiated by MBNL1 but may also increase robustness via the 
modulation of autoregulated RBPs.
T cell activation
Changes in the levels of a master splicing regulator can also trigger an irreversible transition 
between steady states along a single lineage. During T lymphocyte activation, the 
transmembrane receptor CD45 undergoes a splicing switch that has been suggested to 
initiate signaling through antigen receptors (Holmes, 2008). The activity of hnRNPLL is 
necessary and sufficient for the CD45 splicing switch, as well as for several other splicing 
events associated with hematopoietic cell differentiation and activation (Oberdoerffer et al., 
2008; Topp et al., 2008). As a result, hnRNPLL has been hypothesized to be a master 
regulator of T cell activation (Holmes, 2008). hnRNPLL is rapidly upregulated upon 
stimulation of naïve T cells in a manner consistent with transcriptional activation 
(Oberdoerffer et al., 2008). In accordance with the cross-regulation observed in other 
splicing regulatory networks, several SR and hnRNP proteins containing AS-NMD cassettes 
undergo upregulation in two temporally distinct waves (Ip et al., 2011). Although hnRNPLL 
upregulation does not initiate a switch-like response as with Drosophila sex determination, it 
is likely that a cascade of splicing and transcriptional changes are sustained to produce a 
new, stable T cell state after a transient initiating transcriptional signal.
Splicing switches by opposing RBPs
A more common scenario in mammalian systems may be the toggling of splicing networks 
by RBPs that are expressed in a mutually exclusive manner between two conditions. The 
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MBNL1 expression network that becomes activated during cardiac differentiation, for 
example, is likely opposed by an embryonic CELF1 network (Kalsotra et al., 2008). In the 
context of epithelial-mesenchymal transitions, the expression of Epithelial Splicing 
Regulatory Proteins 1 and 2 is quite tightly restricted to differentiated epithelial cell types. In 
contrast, the splicing patterns of less differentiated basal or mesenchymal cell types bear a 
signature of RBFOX2. Depletion of RBFOX2 or exogenous expression of ESRP1 in human 
mesenchymal breast cancer cells causes a partial reversion to an epithelial phenotype, 
suggesting that these factors and their targets play critical opposing roles in defining 
epithelial and mesenchymal cell states (Shapiro et al., 2011).
A particularly well-characterized example of mutual exclusivity in splicing factor expression 
is found in the PTB/PTBP2 switch during neuronal differentiation. The neuronal splicing 
regulator PTBP2 is lowly expressed in most tissues and is upregulated at the protein level in 
neurons. The PTBP2 transcript contains an alternative exon that triggers NMD when 
skipped; inclusion of the exon requires positive transacting factors such as nSR100 in 
neurons, while repression is mediated by PTBP1 in undifferentiated cells (Calarco et al., 
2009; Wollerton et al., 2004). Upon miRNA-mediated downregulation of PTBP1 during 
neuronal differentiation, the negative regulation of PTBP2 is relieved, leading to a switch 
from a PTB-driven to a PTBP2-driven AS network (Boutz et al., 2007; Makeyev et al., 
2007; Spellman et al., 2007; Wollerton et al., 2004). Interestingly, depletion of PTBP1 in 
fibroblasts is sufficient for PTBP2 induction and neuronal trans-differentiation, arguing that 
PTBP1 is a master regulator of the undifferentiated cell state (Xue et al., 2013). It remains to 
be seen whether PTBP2 also regulates the AS-NMD event present in the PTBP1 transcript 
(Wollerton et al., 2004), as this would result in a double-negative feedback loop specifying 
neuronal versus non-neuronal lineages. Such dynamic regulation of otherwise stable splicing 
networks by opposing factors may be a common feature of diverging developmental 
programs.
Homeostatic splicing networks
Another function of a master splicing factor is to reinforce cell identity, for example by 
regulating a specific cell function or by controlling homeostatic splicing events. These 
factors may not be required to specify the cell’s lineage, but may be required to function 
within and respond to its environment. Master splicing regulators acting in this context are 
likely to have targets that work together to form a coherent cellular response. Homeostatic 
RBPs may also be important on short timescales. As intron removal can function as a rate-
limiting step in gene expression (Bhatt et al., 2012), an RBP’s direct targets could be rapidly 
spliced upon its activation. Such temporal properties may be critical in mediating the 
transient and homeostatic responses discussed below.
Nova1/2 neural splicing networks
One of the best-characterized tissue-restricted splicing networks is regulated by the Nova 
proteins, Nova-1 and Nova-2, exclusively in neurons. Nova-1 and Nova-2 exhibit largely 
non-overlapping patterns of expression in different regions of the brain (Yang et al., 1998). 
Nova-1 null mice are born phenotypically normal but die soon after birth due to apoptosis of 
neurons of the hindbrain and ventral spinal cord, implying a survival role within 
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differentiated neurons (Jensen et al., 2000). As with many splicing regulators, Nova proteins 
recognize a short sequence motif (in this case, YCAY) to regulate either exon inclusion or 
skipping, depending on the location of binding with respect to the regulated exon (Ule et al., 
2006). Integrating this RNA map with splicing changes observed in Nova knockout mouse 
brains identified ~700 Nova-dependent splicing targets (Zhang et al., 2010). Many of these 
targets are involved in regulating synapse activity and axonal guidance (Ule et al., 2005). A 
number of Nova targets have also been proposed to interact with one another, suggesting 
that they may comprise a coherent network mediating synaptic plasticity (Ule et al., 2005). 
In addition, the involvement of Nova-2 targets in long-term potentiation has been suggested 
to fine-tune the kinetics and magnitude of neuronal excitability (Huang et al., 2005). These 
studies implicate the Nova proteins in the maintenance of a critical splicing network 
essential for neuronal survival and for controlling synapse activity. The regulation of 
functionally-related genes by a single family of RBPs to reinforce and refine cell identity 
may be a hallmark of master splicing factors.
Transient activation of Rbfox splicing networks
Post-translational modification of RBPs appears to play a critical role in establishing short-
lived or reversible splicing networks. Although at least one Rbfox protein is expressed in a 
large number of tissues, differential activity of each factor may allow the Rbfox network to 
be regulated by unique signals in each tissue. In the brain, Rbfox1 and Rbfox2 show non-
redundant splicing activity despite being expressed in many of the same neuronal cell types 
(Gehman et al., 2012). This is consistent with different modes of regulation for each Rbfox 
protein. For example, Erk1/2 activation by growth factor stimulation results in rapid 
phosphorylation of Rbfox2 in many cell types (M. Jangi and P. Sharp, unpublished 
observations; Carlson et al., 2011). If such post-translational modification results in 
differential localization or association with the splicing machinery, it is possible that the 
Rbfox2 splicing network could be toggled by growth factor signaling. In contrast, Rbfox1 
localization and consequent splicing activity are transiently altered in response to neuronal 
depolarization. This change is self-limiting, as the localization change is reversed by an 
autoregulatory splicing event that antagonizes the effect of depolarization (Lee et al., 2009). 
No analogous shift in localization has been demonstrated for Rbfox2. Thus, since each 
Rbfox protein may respond differently to extracellular, splicing-independent signals and 
may also have unique binding partners, they could potentially regulate non-overlapping, 
reversible splicing networks in distinct contexts. This dynamic may be common to splicing 
factors that exist in paralogous isoforms, such as MBNL, CELF, and NOVA proteins.
Splicing-mediated stress responses
Homeostatic splicing networks have been implicated in coordinating rapid responses to a 
variety of stresses. A number of groups have reported the existence of a subset of introns 
with delayed splicing that seem to play a key part in this response. These introns are 
removed post-transcriptionally, after all other introns in the transcript have been removed, 
prior to export into the cytoplasm. While the initial studies focused on one or two specific 
introns, more recent work suggests that intron “detention” is a regulatory motif within larger 
gene networks (Bhatt et al., 2012; Denis et al., 2005; Hao and Baltimore, 2013; Ninomiya et 
al., 2011). In this manner, a reserve of otherwise completely spliced and polyadenylated 
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messages that still contain one or two introns serves as a buffer, allowing the coordinated 
splicing and export of a large number of genes with precise kinetics upon receipt of a signal. 
This mechanism likely serves as a splicing-regulated positive counterpoint to the negative 
feedback enabled by AS-NMD, as activating splicing in response to signals could increase 
the amount of gene product available. The emerging evidence discussed below indicates that 
detained introns are involved in rapidly correcting deviations from homeostasis caused by 
cellular stressors.
During the splicing cycle, SR proteins undergo sequential phosphorylation and 
dephosphorylation mediated by the SRPK and Clk kinases and protein phosphatases 
(Mermoud et al., 1994; Roscigno and Garcia-Blanco, 1995). Through a mechanism yet to be 
defined, hyperosmotic stress and heat shock inhibit the activity of Clk1/4, leading to SR 
protein dephosphorylation and rapid splicing of SR protein-bound detained introns. One of 
the transcripts undergoing stress-dependent maturation is that encoding Clk1 itself. Detained 
introns surrounding a frame-preserving cassette exon in the Clk1 transcript are rapidly 
removed, thus reestablishing homeostatic levels of Clk kinase activity (Ninomiya et al., 
2011). Beyond this autoregulatory loop, direct inhibition of Clk1/4 leads to expression 
changes of several splicing factors, presumably due to increased splicing of AS-NMD events 
within RBPs crossregulated by SR proteins, and activation of the p53 stress response (P. 
Sharp, unpublished results). These observations suggest that a large post-transcriptional 
regulatory network may be responsible for mediating a rapid and self-limiting cascade of 
transcriptome changes in response to stress signals. Although not an RBP, Clk1 can be 
classified as the master splicing regulator in this context. Interestingly, a significant fraction 
of genes that are differentially spliced upon UV-induced DNA damage encode the NMD 
isoforms of RBPs (Ip et al., 2011). It is possible that intron detention is playing a similar role 
in AS during DNA damage as during heat shock or hyperosmotic stress. Determining 
whether splicing-dependent responses are a common theme within stress responses will 
consolidate the role of splicing in the maintenance of homeostasis.
Master splicing regulators in disease
Evidence for RBPs playing a critical part in determining cell state comes from pathology 
caused by changes in RBP activity. While several genetic diseases have been attributed to 
mutations in cis that disrupt splicing factor binding sites within critical disease genes, many 
arise from the altered function of trans-acting splicing factors. Such disorders tend to have 
pleiotropic effects due to the dysregulation of entire post-transcriptional networks, thus 
shedding light on the targets regulated by the affected splicing factors in normal physiology. 
Disorders resulting in RBP dysfunction can be broadly categorized into RBP loss-of-
function or toxic RNA gain-of-function and can be inherited, arise from autoreactivity, or 
develop in the context of cancer (Cooper et al., 2009). For example, the genetic disorder 
spinal muscular atrophy is the most frequent genetic cause of infant mortality and occurs 
due to loss of the SMN1 gene, encoding a protein involved in snRNP assembly. Although 
SMN1 is ubiquitously expressed, pathology is confined mainly to motor neurons and 
muscle, indicative of a cell-type-specific sensitivity to an altered splicing regulatory network 
(Crawford and Pardo, 1996). Myotonic dystrophy type I is caused by an expanded CUG 
repeat in the first exon of the gene DMPK. This results in nuclear sequestration of MBNL 
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proteins, which bind CUG repeat hairpins, and subsequent disruption of the MBNL splicing 
network across several tissues (Wang et al., 2012). In parallel, CUG repeat expansion leads 
to activation of PKC signaling and hyperphosphorylation and stabilization of CELF 
proteins, further contributing to splicing dysregulation (Kuyumcu-Martinez et al., 2007). 
Recently, the role of apparently constitutive splicing regulators in myelodysplastic 
syndromes and acute myelocytic leukemia has come to the forefront. Recurrent mutations in 
Sf3b1, U2af35, and other splicing factors in these syndromes have suggested that the 
regulation of a specific splicing network influences cell survival and proliferation in 
hematopoietic lineages (Yoshida et al., 2011). Such dysregulation or loss of specific splicing 
regulators in particular contexts argues for the establishment and regulation of broad 
biological networks by a single upstream splicing factor.
Identifying novel master splicing regulators
To expand upon the studies discussed here, how can we identify the master splicing 
regulators of a particular cell state? The input signals that activate splicing networks may 
provide key insights into which factors are contributing most strongly to the network. As 
proposed here, these inputs may frequently be post-translational or transcriptional. While 
transient RBP-dependent changes in cell state are crucial for normal physiology, it has 
proven to be difficult to identify RBP targets of signaling pathways (Heyd and Lynch, 
2011). Here, we will focus on identifying the transcriptional inputs into splicing networks, in 
particular those within irreversible developmental programs.
The emerging wealth of data in transcriptional networks affords a tractable approach to 
identify master splicing regulators in diverse cell systems. It was recently shown that master 
transcription factors bind and regulate a subset of ~250 large transcriptional enhancer 
regions, termed superenhancers, within most cell types (Hnisz et al., 2013). The genes 
proximal to these superenhancers are enriched for key cell state determinants, including 
lineage-specific transcription factors (Hnisz et al., 2013; Whyte et al., 2013). Beyond 
transcription factors, however, many additional genes driven by superenhancers are likely to 
initiate and maintain critical processes during differentiation. The subset of tissue-specific 
splicing factors activated by superenhancers may fit these criteria. Specifically, we propose 
that superenhancer-activated splicing factors could directly and rapidly impact the cellular 
transcriptome as master splicing regulators. In the cases where RBPs are among the primary 
targets of master transcription factors, it is possible that the ectopic activation of such master 
splicing regulators is necessary and sufficient to substantially alter cell identity.
Transcriptional superenhancers at RBP genes
We predict that as with master transcription factors, 1–4 master splicing factors may be 
transcriptionally controlled in any particular cell type. Indeed, across a panel of 86 human 
tissues and cell lines, hierarchical clustering by the presence of a superenhancer near an RBP 
gene separates samples largely by tissue type, with ~4–5 RBP genes associated with a 
superenhancer in each cell type (M. Jangi and P. Sharp, unpublished observations; Hnisz et 
al., 2013). Conversely, individual RBPs may be activated by superenhancers across multiple 
tissues. For example, consistent with a suggested role in initiating and maintaining 
irreversible splicing networks during differentiation, the splicing factor MBNL1 is marked 
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with a superenhancer across several differentiated cell types, including brain, adipose, and 
adult but not fetal gastrointestinal tract (M. Jangi and P. Sharp, unpublished observations; 
Hnisz et al., 2013).
In contrast to master splicing regulators, we posit that secondary splicing regulators would 
contain AS-NMD splicing events cross-regulated by master RBPs and would be less 
strongly transcriptionally modulated. Several previously-identified AS-NMD targets of 
Rbfox2, including Tia1, Tra2a, and Snrnp70, lack transcriptional superenhancers across all 
tissues examined but have varying expression across many of these cell types (Grosso et al., 
2008; Hnisz et al., 2013; Jangi et al., 2014). These observations support the notion that an 
initiating transcriptional signal, indicated by a superenhancer, drives expression of a master 
splicing factor that further regulates a cascade of additional RBPs to establish sustained 
condition-specific splicing networks. Examples of potential master splicing factors activated 
by tissue-specific superenhancers are outlined in Table 1.
RBM24 and RBM38: Conserved drivers of myogenesis
Identification of cell type-specific transcriptional superenhancers proximal to RBPs may 
lead to the discovery of novel master splicing regulators. Skeletal muscle myoblasts, for 
example, possess three splicing factors that are marked with proximal superenhancers. One 
of these is CELF2, a well-studied splicing regulator that has been previously implicated in 
determining muscle-specific splicing patterns (Kalsotra et al., 2008). The remaining two are 
less well-characterized members of the RRM-containing family of RBPs – RBMS3 and 
RBM24 – and also show no evidence of containing AS-NMD splicing events. Little is 
known about the effect of RBMS3 on RNA metabolism, although its primarily cytoplasmic 
localization implies a role in regulating RNA stability as opposed to splicing (Jayasena and 
Bronner, 2012). Interestingly, both Rbm24 and its close paralog Rbm38, which is marked 
with a superenhancer in mature skeletal muscle, have been found to regulate myogenesis in 
part through post-transcriptional regulation of myogenin and p21 (Jin et al., 2010; Miyamoto 
et al., 2009) (Figure 4). Rbm24 is a target of the muscle-specific master transcription factor 
MyoD and may thus establish a post-transcriptional regulatory network early in muscle 
differentiation (Li et al., 2010). Indeed, overexpression of either Rbm24 or Rbm38 promotes 
murine myogenesis, while loss of Rbm24 inhibits myogenesis in both murine and Xenopus 
models (Jin et al., 2010; Li et al., 2010; Miyamoto et al., 2009). The evolutionary 
conservation of this pathway indicates that post-transcriptional regulation affords particular 
advantageous characteristics. In addition, in support of the combinatorial control and co-
regulation that characterizes RBP networks, it has also been speculated that Rbm38 works 
cooperatively to activate Rbfox-dependent splicing specifically in muscle (Heinicke et al., 
2013; Zhang et al., 2008). Rbm24 moreover interacts with Rbfox1 by yeast two-hybrid (Lim 
et al., 2006). These observations may explain the increased use of Rbfox-dependent 
alternative exons in muscle in spite of similar Rbfox expression patterns in muscle compared 
to several other tissues lacking Rbfox splicing signatures (Figure 4). Master RBPs such as 
Rbm24 and Rbm38 could thus have a significant contribution to, and may in some cases be 
sufficient for, the cell type-specific gene expression networks thought to be driven primarily 
by master transcription factors. Taken together, RBPs identified by proximity to 
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transcriptional superenhancers are likely to function as master splicing regulators upstream 
of broad cell type-specific splicing networks.
Future Perspectives
Over the past decade, high-throughput RNA sequencing technologies have advanced the 
study of alternative splicing from a single-regulator, single-target approach to a more global 
analysis of splicing networks. The difficulty now lies in synthesizing the complex 
information generated in these studies within the conceptual framework of a biological 
program. The general systems biology principles presented in this review will aid in the 
parsing of new data into homeostatic, developmental, or as-yet undefined regulatory 
networks.
Identifying the master and secondary splicing regulators driving context-specific splicing 
patterns is being furthered by bioinformatics approaches. Several groups have undertaken 
computational analyses that integrate RBP consensus motifs and other RNA features with 
transcriptomics and RNA-protein interaction maps to identify primary RBP contributors and 
tissue-specific splicing parameters (Barash et al., 2010; Lim et al., 2011; Zhang et al., 2010). 
These “splicing codes” have made apparent that different subsets of genomically-encoded 
cis elements are active in different tissues, suggesting that the balance of splicing factors 
expressed in a given cell type is a primary determinant of its splicing patterns. Moving 
forward, it will be critical to integrate the splicing cascades outlined here into these splicing 
codes to achieve a more comprehensive understanding of the regulatory layers that function 
in different physiological contexts. Such studies will also allow for a more quantitative 
definition of master splicing regulators, for example by requiring a factor to regulate, 
directly and indirectly, a minimum fraction of splicing events in a particular condition to 
qualify as a master regulator.
While a great deal of evidence reinforces the notion that modulation of a single RBP can 
initiate cell state transitions, we posit that a large supporting cast of splicing factors also 
plays crucial roles in establishing and maintaining cell identity. Understanding the co-
regulation of direct and indirect splicing changes, as well as gene expression changes arising 
from transcriptional regulation, will be essential in determining the roles of both master and 
secondary splicing factors in the establishment of tissue transcriptomes. Splicing-
independent roles of RBPs, such as the regulation of mRNA localization and stability, will 
also need to be addressed to define the contribution of various post-transcriptional 
regulatory mechanisms to cell state maintenance. Once identified within larger regulatory 
networks in specific cellular contexts, modulation of master splicing factor levels could 
provide a more precise alternative to transcription factor-based cellular reprogramming and 
manipulation. Future genetic, genomic, and biochemical analyses will elucidate the critical 
and nuanced role of the RBP repertoire in defining gene regulatory networks across 
mammalian development.
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Figure 1. Common motifs in splicing networks
A) Negative feedback of RNA binding proteins (RBPs) occurs when a splicing factor 
regulates a nonsense-mediated decay-coupled splicing event within its own transcript to 
repress its own protein expression and maintain steady state expression levels. B) Top panel: 
Positive feedback in splicing networks can occur through a double negative feedback loop. 
Double negative feedback results from the cross-regulation of two RBPs, producing two 
steady states each characterized by the exclusive expression of one of the RBPs. Bottom 
panel: Positive feedback also arises through composite feedback with a splicing factor (SF) 
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and one or more transcription factors (TF) that results in a double positive feedback loop and 
bistability. In this case, either the SF and TF are both expressed, or the SF and TF are both 
off. Red hexagons indicate premature termination codons.
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Figure 2. RNA binding protein cross-regulation in splicing networks
A) Model for the cross-regulation of an autoregulatory poison exon by Rbfox2. Binding of 
Rbfox2 inhibits inclusion of the poison exon (red hexagon indicates premature termination 
codon), leading to a higher steady-state expression level of the autoregulated protein in the 
presence of Rbfox2. B) Rbfox2 and Ptbp2 function in a splicing cascade during neuronal 
differentiation. Rbfox2 directly regulates a subset of targets involved in cytoskeletal 
organization. In addition, inhibition of autoregulatory splicing of Ptbp2 by Rbfox2 leads to 
Ptbp2 upregulation. Ptbp2, either in conjunction with Rbfox2 or independently, regulates the 
splicing of several genes involved in adherens junction formation. Together, these primary 
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and secondary targets of Rbfox2 contribute to the specification of neural progenitor fate 
(Jangi et al., 2014; Licatalosi et al., 2012).
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Figure 3. Bistability in Drosophila sex determination
The Drosophila sex determination pathway initiates a cascade of splicing events within 
RNA binding proteins and transcription factors that regulates sexual dimorphism. The 
master regulator Sxl drives the female-specific isoform of Tra, which generates female-
specific isoforms of the transcription factors Dsx and Fru. Positive feedback loops are 
indicated as bold arrows. Red hexagon indicates premature termination codon.
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Figure 4. Master splicing factors in myogenesis
Rbm24 and Rbm28 are master RNA binding proteins in skeletal muscle differentiation and 
maintenance. The master transcription factor MyoD activates Rbm24 and Rbm38 in skeletal 
muscle myoblasts, concurrent with E2f-dependent activation of cell proliferation and Rbm38 
activation. In a negative feedback loop that counters E2f activity, Rbm24 and Rbm38 initiate 
exit from the cell cycle by stabilization of p21. Rbm24 drives differentiation through the 
stabilization of the critical myogenesis factor myogenin. Both Rbm24 and Rbm38 control 
muscle-dependent splicing in differentiated myotubes through the co-regulation of Rbfox1 
target splicing events (Jin et al., 2010; Li et al., 2010; Miyamoto et al., 2009; Zhang et al., 
2008). Bottom panel: Rbm24 acquires an active transcriptional superenhancer in skeletal 
muscle myoblasts (yellow and green circles) and retains the mark in differentiated 
myotubes, in which the Rbm38 superenhancer also becomes active (Hnisz et al., 2013).
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Table 1
Superenhancer-driven candidate master RNA binding proteins (RBPs)
RBPs Tissue Targets References
RBM24 Muscle myoblasts Myogenin (Jin et al., 2010; Miyamoto et al., 2009)
RBM38 Skeletal muscle p21 (Jin et al., 2010; Li et al., 2010; Miyamoto et al., 
2009)
RBM20 adult cardiac muscle, Skeletal muscle Titin (Linke and Bucker, 2012)
RBFOX1 Skeletal muscle F1γ, α-actinin (Jin et al., 2003)
RBFOX2 Epithelial cells Fgfr2, Enah, Ctnnd1, 
Fn1
(Shapiro et al., 2011; Venables et al., 2009)
HNRNPA0 Hematopoietic stem cells Egr1/2, Gfi1 (Young et al., 2014)
MBNL1 Brain, adipose, adult gastrointestinal 
tract
FOXP1 (Gabut et al., 2011)
ZNF638/NP220 Brain Unknown n/a
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